Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Sansure Biotech Inc. is currently managing 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct art units, which indicates that the company's filings span several specialized technical groups within the patent office. The prosecution involves 5 distinct examiners, meaning that every pending action is currently being reviewed by a different individual. This high ratio of examiners to actions suggests a broad and decentralized prosecution landscape for the company.
SINES, BRIAN J is designated as the busiest examiner for the portfolio, currently holding 1 busiest examiner pending office action. Although SINES, BRIAN J is the busiest, the 1 busiest examiner pending action represents only a portion of the 5 pending office actions total. The fact that 5 distinct examiners are involved across 3 distinct art units suggests that the company must manage multiple distinct examiner styles. This distribution of 5 pending office actions requires a coordinated effort to maintain consistency across the Biotechnology & Pharmaceuticals portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §102 only | 1 (20%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINES, BRIAN J | 1 | 80.1% | +5.2% |
| EDWARDS, LYDIA E | 1 | 60.2% | +5.8% |
| PRIEST, AARON A | 1 | 61.3% | +25.7% |
| BAUSCH, SARAE L | 1 | 29.8% | +44.7% |
| HAMMELL, NEIL P | 1 | 34.6% | +43.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681762 | COMPOSITON FOR LIQUEFYING VISCOUS BIOLOGICAL SAMPLE, COMBINTATION PRODUCT, LIQUEFYING AGENT, AND KIT THEREOF, AND METHOD AND APPLICATION THEREOF | SINES, BRIAN J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17935281 | REAGENT COMBINATION AND KIT FOR DETECTING LIVER CANCERS, AND USE THEREOF | BAUSCH, SARAE L | 22d |
| 18404646 | MOLECULAR DETECTION SYSTEM AND DETECTION METHOD THEREOF | EDWARDS, LYDIA E | — |
| 18332801 | PRIMER AND PROBE DESIGN METHOD, DETECTION COMPOSITION, AND KIT FOR MIRNA DETECTION | PRIEST, AARON A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17891034 | COMPOSITION, KIT FOR DETECTING MUTATIONS OF 2019 NOVELCORONAVIRUS AND USE THEREOF | HAMMELL, NEIL P | 14d |
| 17935281 | REAGENT COMBINATION AND KIT FOR DETECTING LIVER CANCERS, AND USE THEREOF | BAUSCH, SARAE L | 22d |
| 18332801 | PRIMER AND PROBE DESIGN METHOD, DETECTION COMPOSITION, AND KIT FOR MIRNA DETECTION | PRIEST, AARON A | — |
| Art Unit | Apps |
|---|---|
| 1681 | 3 |
| 1682 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18681762 | COMPOSITON FOR LIQUEFYING VISCOUS BIOLOGICAL SAMPLE, COMBINTATION PRODUCT, LIQUEFYING AGENT, AND KIT THEREOF, AND METHOD AND APPLICATION THEREOF | SINES, BRIAN J | 1682 | §102 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18404646 | MOLECULAR DETECTION SYSTEM AND DETECTION METHOD THEREOF | EDWARDS, LYDIA E | 1681 | §102§103 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18332801 | PRIMER AND PROBE DESIGN METHOD, DETECTION COMPOSITION, AND KIT FOR MIRNA DETECTION | PRIEST, AARON A | 1681 | §102§112 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 17935281 | REAGENT COMBINATION AND KIT FOR DETECTING LIVER CANCERS, AND USE THEREOF | BAUSCH, SARAE L | 1699 | §101§102§112 | Non-Final OA | 22d | Pending | Sep 26, 2022 |
| 17891034 | COMPOSITION, KIT FOR DETECTING MUTATIONS OF 2019 NOVELCORONAVIRUS AND USE THEREOF | HAMMELL, NEIL P | 1681 | §112 | Final Rejection | 14d | Pending | Aug 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial